VOYA Investment Management
PRME icon

VOYA Investment Management’s Prime Medicine PRME Stock Holding History

VOYA Investment Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.3K Buy
20,138
+2,793
+16% +$9.28K ﹤0.01% 2394
2026
Q1 		$60.4K Sell
17,345
-146
-0.8% -$556 ﹤0.01% 2261
2025
Q4 		$60.7K Buy
17,491
+4,642
+36% +$20.6K ﹤0.01% 2322
2025
Q3 		$71.2K Sell
12,849
-4,373
-25% -$17.8K ﹤0.01% 2347
2025
Q2 		$42.5K Hold
17,222
– – ﹤0.01% 2622
2025
Q1 		$34.3K Sell
17,222
-951
-5% -$2.43K ﹤0.01% 2585
2024
Q4 		$53.1K Sell
18,173
-1,011
-5% -$3.55K ﹤0.01% 2671
2024
Q3 		$74.2K Hold
19,184
– – ﹤0.01% 2715
2024
Q2 		$98.6K Buy
19,184
+6,278
+49% +$38.1K ﹤0.01% 2673
2024
Q1 		$90.3K Sell
12,906
-3,254
-20% -$24.7K ﹤0.01% 2633
2023
Q4 		$143K Hold
16,160
– – ﹤0.01% 2671
2023
Q3 		$154K Buy
16,160
+417
+3% +$5.42K ﹤0.01% 2623
2023
Q2 		$231K Buy
+15,743
New +$220K ﹤0.01% 2513

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VOYA Investment Management's PRME Position: Q2 2026 in Review

VOYA Investment Management increased its Prime Medicine (PRME) stake by 16% in Q2 2026, buying an estimated $9.28K and bringing the position to 20,138 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

VOYA Investment Management first reported a position in PRME in Q2 2023 and has held it in 13 quarters since. The position peaked at $231K in Q2 2023. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • VOYA Investment Management held 20,138 shares of Prime Medicine worth $74.3K as of Q2 2026.
  • VOYA Investment Management bought 2,793 Prime Medicine shares in Q2 2026, an estimated $9.28K.
  • Prime Medicine made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2394 holding.
  • VOYA Investment Management first reported a position in Prime Medicine in Q2 2023 and has held it in 13 quarters since.
  • VOYA Investment Management's Prime Medicine position peaked at $231K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.